💊 الأدوية من أ إلى ي 🧬 الأهداف 🛠 الأدوات 📚 الأدلة
جميع الأدوية تصنيفات الأدوية المجالات العلاجية الآثار الجانبية
الأدلة المسرد الجدول الزمني
المقارنات مسارات الأدوية عائلات الأدوية
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Streptokinase

CHEMBL2108147 Phase 4 معتمد Enzyme
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
— g/mol
LogP
—
Phase
4

Derived from streptococcal bacteria, this clot-dissolving enzyme breaks down fibrin, the protein mesh that holds blood clots together, and is used to treat heart attacks, pulmonary embolism, and acute stroke when administered quickly. Because it can cause significant bleeding and allergic reactions, it has been largely superseded by more targeted clot-busting drugs in many settings.

المجالات العلاجية

Cardiovascular Disease Systemic Lupus Erythematosus Stroke Deep Vein Thrombosis / Pulmonary Embolism

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

Derived from streptococcal bacteria, this clot-dissolving enzyme breaks down fibrin, the protein mesh that holds blood clots together, and is used to treat heart attacks, pulmonary embolism, and acute stroke when administered quickly. Because it can cause significant bleeding and allergic reactions, it has been largely superseded by more targeted clot-busting drugs in many settings.

Yes, Streptokinase is an approved drug. It has reached clinical phase 4. It is classified as a Enzyme.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108147. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.